Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
chia-screen-data-Fav | 2.830 | 1.90e-15 | 5.16e-04 | 3.55e-03 |
Gene Symbol | Entrez Gene ID | Frequency | chia-screen-data-Fav gene score | Best subnetwork score | Degree | Chia-Hits Primary | Chia-Hits Secondary |
---|---|---|---|---|---|---|---|
MED19 | 219541 | 30 | -2.657 | 3.449 | 115 | Yes | - |
RHOA | 387 | 5 | -2.408 | 2.845 | 151 | Yes | Yes |
ANXA4 | 307 | 7 | -2.478 | 3.062 | 15 | Yes | Yes |
MED28 | 80306 | 16 | -2.404 | 3.216 | 80 | Yes | - |
YAP1 | 10413 | 94 | -4.256 | 3.538 | 53 | Yes | - |
POU5F1 | 5460 | 133 | -5.148 | 3.538 | 179 | Yes | Yes |
TPR | 7175 | 18 | -2.638 | 3.072 | 28 | Yes | Yes |
APLP2 | 334 | 12 | -2.732 | 3.206 | 35 | Yes | Yes |
PSMD2 | 5708 | 47 | -4.172 | 3.157 | 386 | Yes | Yes |
TBC1D10A | 83874 | 8 | -2.544 | 2.989 | 26 | Yes | - |
ZFP36 | 7538 | 10 | -2.968 | 2.869 | 24 | Yes | Yes |
LUC7L3 | 51747 | 33 | -3.523 | 3.449 | 18 | Yes | - |
NFKB1 | 4790 | 9 | -2.123 | 2.870 | 263 | Yes | - |
MED24 | 9862 | 6 | -2.482 | 3.033 | 39 | Yes | - |
MED12 | 9968 | 14 | -2.465 | 3.206 | 65 | Yes | - |
[ RP2 ] | 6102 | 1 | -0.649 | 2.830 | 5 | - | - |
MED14 | 9282 | 6 | -2.420 | 3.137 | 49 | Yes | - |
NFRKB | 4798 | 48 | -3.129 | 3.108 | 23 | Yes | Yes |
YY1 | 7528 | 24 | -2.572 | 3.120 | 114 | Yes | Yes |
DDIT3 | 1649 | 60 | -2.825 | 3.504 | 343 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
MED28 | 80306 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
MED24 | 9862 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
YAP1 | 10413 | MED28 | 80306 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
MED24 | 9862 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
NFKB1 | 4790 | ZFP36 | 7538 | pp | -- | int.I2D: BioGrid |
APLP2 | 334 | RP2 | 6102 | pp | -- | int.I2D: IntAct_Mouse |
DDIT3 | 1649 | NFKB1 | 4790 | pp | -- | int.I2D: BEHRENDS_AUTOPHAGY_LOW |
MED14 | 9282 | MED12 | 9968 | pp | -- | int.I2D: BioGrid |
APLP2 | 334 | MED12 | 9968 | pp | -- | int.I2D: MINT; int.Mint: MI:0407(direct interaction) |
MED14 | 9282 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
RHOA | 387 | PSMD2 | 5708 | pp | -- | int.I2D: BioGrid_Yeast |
NFKB1 | 4790 | YY1 | 7528 | pp | -- | int.Intact: MI:0915(physical association) |
APLP2 | 334 | RHOA | 387 | pp | -- | int.I2D: IntAct_Mouse |
NFKB1 | 4790 | NFRKB | 4798 | pp | -- | int.I2D: BCI, HPRD; int.Ravasi: -; int.HPRD: in vitro |
NFRKB | 4798 | YY1 | 7528 | pp | -- | int.I2D: BioGrid |
MED12 | 9968 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
MED12 | 9968 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct |
APLP2 | 334 | NFKB1 | 4790 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
MED24 | 9862 | MED12 | 9968 | pp | -- | int.I2D: BioGrid |
LUC7L3 | 51747 | MED19 | 219541 | pp | -- | int.Intact: MI:0914(association); int.I2D: IntAct |
NFKB1 | 4790 | TPR | 7175 | pp | -- | int.I2D: MINT; int.Mint: MI:0915(physical association) |
NFRKB | 4798 | POU5F1 | 5460 | pp | -- | int.I2D: BioGrid_Mouse, IntAct_Mouse |
MED14 | 9282 | MED28 | 80306 | pp | -- | int.I2D: BioGrid |
RHOA | 387 | TBC1D10A | 83874 | pp | -- | int.I2D: BioGrid_Yeast |
ANXA4 | 307 | NFKB1 | 4790 | pp | -- | int.I2D: BioGrid, INNATEDB |
MED14 | 9282 | MED24 | 9862 | pp | -- | int.I2D: BioGrid |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0016592 | mediator complex | 9.43e-10 | 1.36e-05 | 6.687 | 5 | 10 | 35 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 1.07e-07 | 1.55e-03 | 6.450 | 4 | 8 | 33 |
GO:0019827 | stem cell maintenance | 4.62e-07 | 6.66e-03 | 5.940 | 4 | 7 | 47 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 8.22e-07 | 1.19e-02 | 7.272 | 3 | 6 | 14 |
GO:0042809 | vitamin D receptor binding | 1.03e-06 | 1.48e-02 | 7.172 | 3 | 6 | 15 |
GO:0044212 | transcription regulatory region DNA binding | 2.72e-06 | 3.92e-02 | 4.424 | 5 | 17 | 168 |
GO:0005654 | nucleoplasm | 5.73e-06 | 8.27e-02 | 2.585 | 9 | 64 | 1082 |
GO:0046966 | thyroid hormone receptor binding | 5.81e-06 | 8.38e-02 | 6.379 | 3 | 6 | 26 |
GO:0030521 | androgen receptor signaling pathway | 2.35e-05 | 3.39e-01 | 5.722 | 3 | 5 | 41 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.45e-05 | 3.53e-01 | 3.772 | 5 | 23 | 264 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 2.72e-05 | 3.92e-01 | 5.653 | 3 | 7 | 43 |
GO:0003712 | transcription cofactor activity | 2.91e-05 | 4.20e-01 | 5.620 | 3 | 8 | 44 |
GO:0005634 | nucleus | 8.37e-05 | 1.00e+00 | 1.247 | 15 | 159 | 4559 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.06e-04 | 1.00e+00 | 3.971 | 4 | 22 | 184 |
GO:0003729 | mRNA binding | 1.28e-04 | 1.00e+00 | 4.909 | 3 | 4 | 72 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.41e-04 | 1.00e+00 | 6.794 | 2 | 2 | 13 |
GO:0031011 | Ino80 complex | 1.65e-04 | 1.00e+00 | 6.687 | 2 | 6 | 14 |
GO:0010467 | gene expression | 2.16e-04 | 1.00e+00 | 2.693 | 6 | 45 | 669 |
GO:0003713 | transcription coactivator activity | 2.80e-04 | 1.00e+00 | 3.605 | 4 | 24 | 237 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.02e-04 | 1.00e+00 | 2.915 | 5 | 24 | 478 |
GO:0005515 | protein binding | 5.64e-04 | 1.00e+00 | 0.938 | 16 | 198 | 6024 |
GO:0042594 | response to starvation | 8.29e-04 | 1.00e+00 | 5.540 | 2 | 4 | 31 |
GO:0003677 | DNA binding | 8.73e-04 | 1.00e+00 | 2.051 | 7 | 49 | 1218 |
GO:0031072 | heat shock protein binding | 9.40e-04 | 1.00e+00 | 5.450 | 2 | 2 | 33 |
GO:0006974 | cellular response to DNA damage stimulus | 1.13e-03 | 1.00e+00 | 3.841 | 3 | 7 | 151 |
GO:1901673 | regulation of spindle assembly involved in mitosis | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0043578 | nuclear matrix organization | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0045083 | negative regulation of interleukin-12 biosynthetic process | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0006404 | RNA import into nucleus | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0031453 | positive regulation of heterochromatin assembly | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:1990075 | periciliary membrane compartment | 1.39e-03 | 1.00e+00 | 9.494 | 1 | 1 | 1 |
GO:0003714 | transcription corepressor activity | 1.81e-03 | 1.00e+00 | 3.603 | 3 | 11 | 178 |
GO:0004872 | receptor activity | 2.14e-03 | 1.00e+00 | 3.517 | 3 | 8 | 189 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.35e-03 | 1.00e+00 | 2.783 | 4 | 30 | 419 |
GO:0050728 | negative regulation of inflammatory response | 2.69e-03 | 1.00e+00 | 4.687 | 2 | 3 | 56 |
GO:0060242 | contact inhibition | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:0031990 | mRNA export from nucleus in response to heat stress | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 2 | 2 |
GO:0006403 | RNA localization | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:2000483 | negative regulation of interleukin-8 secretion | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:0070840 | dynein complex binding | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:0046832 | negative regulation of RNA export from nucleus | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:0034696 | response to prostaglandin F | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:0000189 | MAPK import into nucleus | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 2.77e-03 | 1.00e+00 | 8.494 | 1 | 1 | 2 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.77e-03 | 1.00e+00 | 2.192 | 5 | 41 | 789 |
GO:0046914 | transition metal ion binding | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:0042306 | regulation of protein import into nucleus | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 3 |
GO:0060913 | cardiac cell fate determination | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:1900127 | positive regulation of hyaluronan biosynthetic process | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:0090245 | axis elongation involved in somitogenesis | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:0050779 | RNA destabilization | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:0033256 | I-kappaB/NF-kappaB complex | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:0006405 | RNA export from nucleus | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 2 | 3 |
GO:0033688 | regulation of osteoblast proliferation | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 4.15e-03 | 1.00e+00 | 7.909 | 1 | 1 | 3 |
GO:0008134 | transcription factor binding | 4.31e-03 | 1.00e+00 | 3.160 | 3 | 18 | 242 |
GO:0032680 | regulation of tumor necrosis factor production | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0014044 | Schwann cell development | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0032375 | negative regulation of cholesterol transport | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0051151 | negative regulation of smooth muscle cell differentiation | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0032269 | negative regulation of cellular protein metabolic process | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:2000630 | positive regulation of miRNA metabolic process | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0006999 | nuclear pore organization | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0044615 | nuclear pore nuclear basket | 5.54e-03 | 1.00e+00 | 7.494 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0019957 | C-C chemokine binding | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0007023 | post-chaperonin tubulin folding pathway | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 2 | 5 |
GO:0010884 | positive regulation of lipid storage | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0035925 | mRNA 3'-UTR AU-rich region binding | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0010793 | regulation of mRNA export from nucleus | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0070849 | response to epidermal growth factor | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 5 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 7.06e-03 | 1.00e+00 | 2.339 | 4 | 37 | 570 |
GO:0004859 | phospholipase inhibitor activity | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 1 | 6 |
GO:0036089 | cleavage furrow formation | 8.29e-03 | 1.00e+00 | 6.909 | 1 | 2 | 6 |
GO:0046825 | regulation of protein export from nucleus | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 2 | 7 |
GO:0071354 | cellular response to interleukin-6 | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 2 | 7 |
GO:0043931 | ossification involved in bone maturation | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 7 |
GO:0043297 | apical junction assembly | 9.67e-03 | 1.00e+00 | 6.687 | 1 | 1 | 7 |
GO:0006355 | regulation of transcription, DNA-templated | 1.01e-02 | 1.00e+00 | 1.855 | 5 | 43 | 997 |
GO:0097202 | activation of cysteine-type endopeptidase activity | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 8 |
GO:0051292 | nuclear pore complex assembly | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 4 | 8 |
GO:0007617 | mating behavior | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 8 |
GO:0071316 | cellular response to nicotine | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 8 |
GO:0035457 | cellular response to interferon-alpha | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 8 |
GO:0006183 | GTP biosynthetic process | 1.10e-02 | 1.00e+00 | 6.494 | 1 | 1 | 8 |
GO:0042405 | nuclear inclusion body | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 9 |
GO:0000975 | regulatory region DNA binding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 9 |
GO:0010225 | response to UV-C | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 9 |
GO:0006228 | UTP biosynthetic process | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 9 |
GO:0035278 | negative regulation of translation involved in gene silencing by miRNA | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 9 |
GO:0043495 | protein anchor | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 9 |
GO:0000400 | four-way junction DNA binding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 9 |
GO:0006241 | CTP biosynthetic process | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 9 |
GO:0043296 | apical junction complex | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 1 | 9 |
GO:0060071 | Wnt signaling pathway, planar cell polarity pathway | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 10 |
GO:0090307 | spindle assembly involved in mitosis | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 10 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 10 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 1.42e-02 | 1.00e+00 | 2.045 | 4 | 39 | 699 |
GO:0045662 | negative regulation of myoblast differentiation | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 3 | 11 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 2 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 1.52e-02 | 1.00e+00 | 6.035 | 1 | 4 | 11 |
GO:0006878 | cellular copper ion homeostasis | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 12 |
GO:0006402 | mRNA catabolic process | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 12 |
GO:0045947 | negative regulation of translational initiation | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 2 | 12 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 3 | 12 |
GO:0034399 | nuclear periphery | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 5 | 12 |
GO:0005838 | proteasome regulatory particle | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.65e-02 | 1.00e+00 | 5.909 | 1 | 1 | 12 |
GO:0071480 | cellular response to gamma radiation | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 13 |
GO:0046688 | response to copper ion | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 13 |
GO:0006165 | nucleoside diphosphate phosphorylation | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 13 |
GO:0051019 | mitogen-activated protein kinase binding | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 2 | 13 |
GO:0005868 | cytoplasmic dynein complex | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 2 | 13 |
GO:0046827 | positive regulation of protein export from nucleus | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 13 |
GO:0010744 | positive regulation of macrophage derived foam cell differentiation | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 14 |
GO:0001967 | suckling behavior | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 14 |
GO:0004550 | nucleoside diphosphate kinase activity | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 14 |
GO:0005685 | U1 snRNP | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 14 |
GO:0031293 | membrane protein intracellular domain proteolysis | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 1 | 14 |
GO:0017091 | AU-rich element binding | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 2 | 14 |
GO:0071375 | cellular response to peptide hormone stimulus | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 2 | 14 |
GO:0005487 | nucleocytoplasmic transporter activity | 1.92e-02 | 1.00e+00 | 5.687 | 1 | 3 | 14 |
GO:0043066 | negative regulation of apoptotic process | 1.98e-02 | 1.00e+00 | 2.351 | 3 | 16 | 424 |
GO:0042307 | positive regulation of protein import into nucleus | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 4 | 15 |
GO:0001824 | blastocyst development | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 2 | 15 |
GO:0006376 | mRNA splice site selection | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 1 | 15 |
GO:0042176 | regulation of protein catabolic process | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 2 | 16 |
GO:0001190 | RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 2 | 16 |
GO:0051276 | chromosome organization | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 2 | 16 |
GO:0045638 | negative regulation of myeloid cell differentiation | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 1 | 16 |
GO:0048593 | camera-type eye morphogenesis | 2.20e-02 | 1.00e+00 | 5.494 | 1 | 1 | 16 |
GO:0031965 | nuclear membrane | 2.23e-02 | 1.00e+00 | 3.102 | 2 | 10 | 168 |
GO:0050919 | negative chemotaxis | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 17 |
GO:0017022 | myosin binding | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 2 | 17 |
GO:0012506 | vesicle membrane | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 17 |
GO:0090316 | positive regulation of intracellular protein transport | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 2 | 17 |
GO:0022624 | proteasome accessory complex | 2.33e-02 | 1.00e+00 | 5.407 | 1 | 1 | 17 |
GO:0005667 | transcription factor complex | 2.41e-02 | 1.00e+00 | 3.043 | 2 | 17 | 175 |
GO:0050772 | positive regulation of axonogenesis | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 18 |
GO:0071889 | 14-3-3 protein binding | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 2 | 18 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 2.47e-02 | 1.00e+00 | 5.324 | 1 | 1 | 18 |
GO:0050771 | negative regulation of axonogenesis | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 1 | 20 |
GO:0032757 | positive regulation of interleukin-8 production | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 1 | 20 |
GO:0014003 | oligodendrocyte development | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 5 | 20 |
GO:0043393 | regulation of protein binding | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 1 | 20 |
GO:0045862 | positive regulation of proteolysis | 2.87e-02 | 1.00e+00 | 5.102 | 1 | 2 | 21 |
GO:0030864 | cortical actin cytoskeleton | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 1 | 23 |
GO:0016573 | histone acetylation | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 2 | 23 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 3.14e-02 | 1.00e+00 | 4.971 | 1 | 1 | 23 |
GO:1902017 | regulation of cilium assembly | 3.28e-02 | 1.00e+00 | 4.909 | 1 | 2 | 24 |
GO:0006611 | protein export from nucleus | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 3 | 25 |
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 3 | 25 |
GO:0031519 | PcG protein complex | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 1 | 25 |
GO:0051059 | NF-kappaB binding | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 3 | 25 |
GO:0035329 | hippo signaling | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 5 | 26 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 3 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 26 |
GO:0050770 | regulation of axonogenesis | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 26 |
GO:0016032 | viral process | 3.60e-02 | 1.00e+00 | 2.018 | 3 | 26 | 534 |
GO:0015631 | tubulin binding | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 27 |
GO:0032467 | positive regulation of cytokinesis | 3.68e-02 | 1.00e+00 | 4.739 | 1 | 2 | 27 |
GO:0016071 | mRNA metabolic process | 3.77e-02 | 1.00e+00 | 2.693 | 2 | 8 | 223 |
GO:0003727 | single-stranded RNA binding | 3.81e-02 | 1.00e+00 | 4.687 | 1 | 2 | 28 |
GO:0034605 | cellular response to heat | 3.81e-02 | 1.00e+00 | 4.687 | 1 | 1 | 28 |
GO:0030901 | midbrain development | 3.95e-02 | 1.00e+00 | 4.636 | 1 | 1 | 29 |
GO:0072686 | mitotic spindle | 3.95e-02 | 1.00e+00 | 4.636 | 1 | 3 | 29 |
GO:0006606 | protein import into nucleus | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 2 | 30 |
GO:0031647 | regulation of protein stability | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 4 | 30 |
GO:0010827 | regulation of glucose transport | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 4 | 30 |
GO:0034644 | cellular response to UV | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 1 | 30 |
GO:0005544 | calcium-dependent phospholipid binding | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 1 | 30 |
GO:0010494 | cytoplasmic stress granule | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 2 | 30 |
GO:0007094 | mitotic spindle assembly checkpoint | 4.21e-02 | 1.00e+00 | 4.540 | 1 | 3 | 31 |
GO:0071347 | cellular response to interleukin-1 | 4.21e-02 | 1.00e+00 | 4.540 | 1 | 2 | 31 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 4.35e-02 | 1.00e+00 | 4.494 | 1 | 2 | 32 |
GO:0005829 | cytosol | 4.44e-02 | 1.00e+00 | 1.016 | 7 | 86 | 2496 |
GO:0016070 | RNA metabolic process | 4.53e-02 | 1.00e+00 | 2.546 | 2 | 8 | 247 |
GO:0005097 | Rab GTPase activator activity | 4.61e-02 | 1.00e+00 | 4.407 | 1 | 1 | 34 |
GO:0030178 | negative regulation of Wnt signaling pathway | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 4 | 35 |
GO:0007077 | mitotic nuclear envelope disassembly | 4.88e-02 | 1.00e+00 | 4.324 | 1 | 4 | 36 |
GO:0005902 | microvillus | 5.14e-02 | 1.00e+00 | 4.246 | 1 | 3 | 38 |
GO:0051496 | positive regulation of stress fiber assembly | 5.14e-02 | 1.00e+00 | 4.246 | 1 | 4 | 38 |
GO:0032154 | cleavage furrow | 5.14e-02 | 1.00e+00 | 4.246 | 1 | 1 | 38 |
GO:0003779 | actin binding | 5.18e-02 | 1.00e+00 | 2.439 | 2 | 10 | 266 |
GO:0008645 | hexose transport | 5.27e-02 | 1.00e+00 | 4.209 | 1 | 4 | 39 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 5.28e-02 | 1.00e+00 | 2.423 | 2 | 7 | 269 |
GO:0044822 | poly(A) RNA binding | 5.40e-02 | 1.00e+00 | 1.450 | 4 | 50 | 1056 |
GO:0035019 | somatic stem cell maintenance | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 6 | 40 |
GO:0050885 | neuromuscular process controlling balance | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 2 | 40 |
GO:0042147 | retrograde transport, endosome to Golgi | 5.54e-02 | 1.00e+00 | 4.137 | 1 | 1 | 41 |
GO:0006954 | inflammatory response | 5.56e-02 | 1.00e+00 | 2.380 | 2 | 6 | 277 |
GO:0019898 | extrinsic component of membrane | 5.67e-02 | 1.00e+00 | 4.102 | 1 | 2 | 42 |
GO:0006892 | post-Golgi vesicle-mediated transport | 5.80e-02 | 1.00e+00 | 4.068 | 1 | 2 | 43 |
GO:0004402 | histone acetyltransferase activity | 5.80e-02 | 1.00e+00 | 4.068 | 1 | 6 | 43 |
GO:0021762 | substantia nigra development | 5.93e-02 | 1.00e+00 | 4.035 | 1 | 4 | 44 |
GO:0043525 | positive regulation of neuron apoptotic process | 6.19e-02 | 1.00e+00 | 3.971 | 1 | 4 | 46 |
GO:0007266 | Rho protein signal transduction | 6.32e-02 | 1.00e+00 | 3.940 | 1 | 1 | 47 |
GO:0090263 | positive regulation of canonical Wnt signaling pathway | 6.45e-02 | 1.00e+00 | 3.909 | 1 | 3 | 48 |
GO:0000902 | cell morphogenesis | 6.58e-02 | 1.00e+00 | 3.879 | 1 | 4 | 49 |
GO:0030900 | forebrain development | 6.58e-02 | 1.00e+00 | 3.879 | 1 | 1 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 6.71e-02 | 1.00e+00 | 3.850 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 6.71e-02 | 1.00e+00 | 3.850 | 1 | 4 | 50 |
GO:0030334 | regulation of cell migration | 6.71e-02 | 1.00e+00 | 3.850 | 1 | 5 | 50 |
GO:0005525 | GTP binding | 6.79e-02 | 1.00e+00 | 2.218 | 2 | 12 | 310 |
GO:0034976 | response to endoplasmic reticulum stress | 6.84e-02 | 1.00e+00 | 3.822 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 6.84e-02 | 1.00e+00 | 3.822 | 1 | 1 | 51 |
GO:0009611 | response to wounding | 6.97e-02 | 1.00e+00 | 3.794 | 1 | 5 | 52 |
GO:0032851 | positive regulation of Rab GTPase activity | 7.10e-02 | 1.00e+00 | 3.766 | 1 | 2 | 53 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 7.10e-02 | 1.00e+00 | 3.766 | 1 | 5 | 53 |
GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 7.10e-02 | 1.00e+00 | 3.766 | 1 | 4 | 53 |
GO:0015758 | glucose transport | 7.36e-02 | 1.00e+00 | 3.713 | 1 | 4 | 55 |
GO:0000724 | double-strand break repair via homologous recombination | 7.36e-02 | 1.00e+00 | 3.713 | 1 | 2 | 55 |
GO:0003682 | chromatin binding | 7.45e-02 | 1.00e+00 | 2.141 | 2 | 19 | 327 |
GO:0016020 | membrane | 7.47e-02 | 1.00e+00 | 1.101 | 5 | 46 | 1681 |
GO:0051291 | protein heterooligomerization | 7.49e-02 | 1.00e+00 | 3.687 | 1 | 4 | 56 |
GO:0048306 | calcium-dependent protein binding | 7.49e-02 | 1.00e+00 | 3.687 | 1 | 2 | 56 |
GO:0036064 | ciliary basal body | 7.62e-02 | 1.00e+00 | 3.661 | 1 | 2 | 57 |
GO:0008203 | cholesterol metabolic process | 7.62e-02 | 1.00e+00 | 3.661 | 1 | 2 | 57 |
GO:0005643 | nuclear pore | 7.62e-02 | 1.00e+00 | 3.661 | 1 | 11 | 57 |
GO:0000502 | proteasome complex | 7.75e-02 | 1.00e+00 | 3.636 | 1 | 3 | 58 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 7.88e-02 | 1.00e+00 | 3.612 | 1 | 6 | 59 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 7.88e-02 | 1.00e+00 | 3.612 | 1 | 5 | 59 |
GO:0008013 | beta-catenin binding | 8.00e-02 | 1.00e+00 | 3.587 | 1 | 9 | 60 |
GO:0030855 | epithelial cell differentiation | 8.13e-02 | 1.00e+00 | 3.563 | 1 | 1 | 61 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 8.13e-02 | 1.00e+00 | 3.563 | 1 | 2 | 61 |
GO:0032481 | positive regulation of type I interferon production | 8.13e-02 | 1.00e+00 | 3.563 | 1 | 6 | 61 |
GO:0043565 | sequence-specific DNA binding | 8.21e-02 | 1.00e+00 | 2.060 | 2 | 11 | 346 |
GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 3 | 63 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 3 | 63 |
GO:0000776 | kinetochore | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 5 | 63 |
GO:0045666 | positive regulation of neuron differentiation | 8.39e-02 | 1.00e+00 | 3.517 | 1 | 3 | 63 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 8.52e-02 | 1.00e+00 | 3.494 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 8.64e-02 | 1.00e+00 | 3.472 | 1 | 2 | 65 |
GO:0006310 | DNA recombination | 8.64e-02 | 1.00e+00 | 3.472 | 1 | 7 | 65 |
GO:0071260 | cellular response to mechanical stimulus | 8.64e-02 | 1.00e+00 | 3.472 | 1 | 4 | 65 |
GO:0034166 | toll-like receptor 10 signaling pathway | 8.64e-02 | 1.00e+00 | 3.472 | 1 | 4 | 65 |
GO:0034146 | toll-like receptor 5 signaling pathway | 8.64e-02 | 1.00e+00 | 3.472 | 1 | 4 | 65 |
GO:0010468 | regulation of gene expression | 9.02e-02 | 1.00e+00 | 3.407 | 1 | 2 | 68 |
GO:0005925 | focal adhesion | 9.04e-02 | 1.00e+00 | 1.978 | 2 | 9 | 366 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 9.28e-02 | 1.00e+00 | 3.365 | 1 | 2 | 70 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 9.40e-02 | 1.00e+00 | 3.344 | 1 | 5 | 71 |
GO:0038123 | toll-like receptor TLR1:TLR2 signaling pathway | 9.40e-02 | 1.00e+00 | 3.344 | 1 | 4 | 71 |
GO:0007626 | locomotory behavior | 9.40e-02 | 1.00e+00 | 3.344 | 1 | 2 | 71 |
GO:0038124 | toll-like receptor TLR6:TLR2 signaling pathway | 9.40e-02 | 1.00e+00 | 3.344 | 1 | 4 | 71 |
GO:0043086 | negative regulation of catalytic activity | 9.53e-02 | 1.00e+00 | 3.324 | 1 | 2 | 72 |
GO:0034162 | toll-like receptor 9 signaling pathway | 9.53e-02 | 1.00e+00 | 3.324 | 1 | 4 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 9.53e-02 | 1.00e+00 | 3.324 | 1 | 1 | 72 |
GO:0034134 | toll-like receptor 2 signaling pathway | 9.66e-02 | 1.00e+00 | 3.304 | 1 | 4 | 73 |
GO:0002020 | protease binding | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 6 | 74 |
GO:0001843 | neural tube closure | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 2 | 74 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 9.78e-02 | 1.00e+00 | 3.285 | 1 | 2 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 9.91e-02 | 1.00e+00 | 3.265 | 1 | 1 | 75 |
GO:0060070 | canonical Wnt signaling pathway | 9.91e-02 | 1.00e+00 | 3.265 | 1 | 4 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 9.91e-02 | 1.00e+00 | 3.265 | 1 | 1 | 75 |
GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 1.00e-01 | 1.00e+00 | 3.246 | 1 | 3 | 76 |
GO:0000278 | mitotic cell cycle | 1.01e-01 | 1.00e+00 | 1.883 | 2 | 15 | 391 |
GO:0070062 | extracellular vesicular exosome | 1.01e-01 | 1.00e+00 | 0.850 | 6 | 57 | 2400 |
GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 3 | 78 |
GO:0034138 | toll-like receptor 3 signaling pathway | 1.04e-01 | 1.00e+00 | 3.190 | 1 | 3 | 79 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 1.04e-01 | 1.00e+00 | 3.190 | 1 | 2 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.04e-01 | 1.00e+00 | 3.190 | 1 | 2 | 79 |
GO:0005814 | centriole | 1.04e-01 | 1.00e+00 | 3.190 | 1 | 2 | 79 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.05e-01 | 1.00e+00 | 3.172 | 1 | 5 | 80 |
GO:0071222 | cellular response to lipopolysaccharide | 1.07e-01 | 1.00e+00 | 3.154 | 1 | 4 | 81 |
GO:0009653 | anatomical structure morphogenesis | 1.09e-01 | 1.00e+00 | 3.119 | 1 | 2 | 83 |
GO:0009952 | anterior/posterior pattern specification | 1.09e-01 | 1.00e+00 | 3.119 | 1 | 4 | 83 |
GO:0050852 | T cell receptor signaling pathway | 1.12e-01 | 1.00e+00 | 3.085 | 1 | 2 | 85 |
GO:0003690 | double-stranded DNA binding | 1.13e-01 | 1.00e+00 | 3.068 | 1 | 3 | 86 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 1.13e-01 | 1.00e+00 | 3.068 | 1 | 8 | 86 |
GO:0006979 | response to oxidative stress | 1.14e-01 | 1.00e+00 | 3.051 | 1 | 6 | 87 |
GO:0016363 | nuclear matrix | 1.19e-01 | 1.00e+00 | 2.986 | 1 | 6 | 91 |
GO:0007010 | cytoskeleton organization | 1.19e-01 | 1.00e+00 | 2.986 | 1 | 4 | 91 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.20e-01 | 1.00e+00 | 2.971 | 1 | 1 | 92 |
GO:0051082 | unfolded protein binding | 1.21e-01 | 1.00e+00 | 2.955 | 1 | 7 | 93 |
GO:0005770 | late endosome | 1.21e-01 | 1.00e+00 | 2.955 | 1 | 2 | 93 |
GO:0030165 | PDZ domain binding | 1.23e-01 | 1.00e+00 | 2.940 | 1 | 1 | 94 |
GO:0034142 | toll-like receptor 4 signaling pathway | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 4 | 96 |
GO:0005096 | GTPase activator activity | 1.32e-01 | 1.00e+00 | 2.822 | 1 | 2 | 102 |
GO:0005886 | plasma membrane | 1.33e-01 | 1.00e+00 | 0.745 | 6 | 49 | 2582 |
GO:0031410 | cytoplasmic vesicle | 1.34e-01 | 1.00e+00 | 2.808 | 1 | 4 | 103 |
GO:0010951 | negative regulation of endopeptidase activity | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 6 | 104 |
GO:0005938 | cell cortex | 1.35e-01 | 1.00e+00 | 2.794 | 1 | 5 | 104 |
GO:0030496 | midbody | 1.40e-01 | 1.00e+00 | 2.739 | 1 | 2 | 108 |
GO:0002224 | toll-like receptor signaling pathway | 1.41e-01 | 1.00e+00 | 2.726 | 1 | 4 | 109 |
GO:0042802 | identical protein binding | 1.44e-01 | 1.00e+00 | 1.575 | 2 | 19 | 484 |
GO:0005635 | nuclear envelope | 1.46e-01 | 1.00e+00 | 2.674 | 1 | 5 | 113 |
GO:0048015 | phosphatidylinositol-mediated signaling | 1.47e-01 | 1.00e+00 | 2.661 | 1 | 2 | 114 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.48e-01 | 1.00e+00 | 2.649 | 1 | 3 | 115 |
GO:0000209 | protein polyubiquitination | 1.49e-01 | 1.00e+00 | 2.636 | 1 | 3 | 116 |
GO:0008201 | heparin binding | 1.56e-01 | 1.00e+00 | 2.563 | 1 | 1 | 122 |
GO:0030036 | actin cytoskeleton organization | 1.58e-01 | 1.00e+00 | 2.552 | 1 | 3 | 123 |
GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 1.59e-01 | 1.00e+00 | 2.540 | 1 | 5 | 124 |
GO:0007050 | cell cycle arrest | 1.59e-01 | 1.00e+00 | 2.540 | 1 | 5 | 124 |
GO:0030027 | lamellipodium | 1.60e-01 | 1.00e+00 | 2.528 | 1 | 7 | 125 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.63e-01 | 1.00e+00 | 2.494 | 1 | 11 | 128 |
GO:0005215 | transporter activity | 1.66e-01 | 1.00e+00 | 2.472 | 1 | 3 | 130 |
GO:0016055 | Wnt signaling pathway | 1.75e-01 | 1.00e+00 | 2.386 | 1 | 4 | 138 |
GO:0007507 | heart development | 1.76e-01 | 1.00e+00 | 2.375 | 1 | 7 | 139 |
GO:0006915 | apoptotic process | 1.79e-01 | 1.00e+00 | 1.378 | 2 | 12 | 555 |
GO:0006457 | protein folding | 1.81e-01 | 1.00e+00 | 2.334 | 1 | 7 | 143 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.83e-01 | 1.00e+00 | 2.314 | 1 | 4 | 145 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.88e-01 | 1.00e+00 | 2.275 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 1.89e-01 | 1.00e+00 | 2.265 | 1 | 4 | 150 |
GO:0007601 | visual perception | 1.97e-01 | 1.00e+00 | 2.200 | 1 | 5 | 157 |
GO:0042803 | protein homodimerization activity | 1.99e-01 | 1.00e+00 | 1.277 | 2 | 19 | 595 |
GO:0008022 | protein C-terminus binding | 2.01e-01 | 1.00e+00 | 2.163 | 1 | 8 | 161 |
GO:0038095 | Fc-epsilon receptor signaling pathway | 2.09e-01 | 1.00e+00 | 2.102 | 1 | 5 | 168 |
GO:0034641 | cellular nitrogen compound metabolic process | 2.12e-01 | 1.00e+00 | 2.076 | 1 | 2 | 171 |
GO:0016607 | nuclear speck | 2.13e-01 | 1.00e+00 | 2.068 | 1 | 12 | 172 |
GO:0031625 | ubiquitin protein ligase binding | 2.20e-01 | 1.00e+00 | 2.018 | 1 | 5 | 178 |
GO:0019904 | protein domain specific binding | 2.21e-01 | 1.00e+00 | 2.010 | 1 | 8 | 179 |
GO:0043547 | positive regulation of GTPase activity | 2.22e-01 | 1.00e+00 | 2.002 | 1 | 9 | 180 |
GO:0003924 | GTPase activity | 2.41e-01 | 1.00e+00 | 1.872 | 1 | 7 | 197 |
GO:0030168 | platelet activation | 2.49e-01 | 1.00e+00 | 1.815 | 1 | 6 | 205 |
GO:0005737 | cytoplasm | 2.51e-01 | 1.00e+00 | 0.422 | 7 | 124 | 3767 |
GO:0006184 | GTP catabolic process | 2.59e-01 | 1.00e+00 | 1.753 | 1 | 7 | 214 |
GO:0019221 | cytokine-mediated signaling pathway | 2.66e-01 | 1.00e+00 | 1.706 | 1 | 8 | 221 |
GO:0007067 | mitotic nuclear division | 2.72e-01 | 1.00e+00 | 1.668 | 1 | 6 | 227 |
GO:0008380 | RNA splicing | 2.73e-01 | 1.00e+00 | 1.661 | 1 | 22 | 228 |
GO:0005975 | carbohydrate metabolic process | 2.98e-01 | 1.00e+00 | 1.511 | 1 | 8 | 253 |
GO:0006281 | DNA repair | 3.06e-01 | 1.00e+00 | 1.466 | 1 | 14 | 261 |
GO:0007283 | spermatogenesis | 3.07e-01 | 1.00e+00 | 1.461 | 1 | 3 | 262 |
GO:0007264 | small GTPase mediated signal transduction | 3.24e-01 | 1.00e+00 | 1.370 | 1 | 3 | 279 |
GO:0030198 | extracellular matrix organization | 3.27e-01 | 1.00e+00 | 1.349 | 1 | 6 | 283 |
GO:0007186 | G-protein coupled receptor signaling pathway | 3.33e-01 | 1.00e+00 | 1.319 | 1 | 1 | 289 |
GO:0005856 | cytoskeleton | 3.35e-01 | 1.00e+00 | 1.309 | 1 | 9 | 291 |
GO:0030154 | cell differentiation | 3.44e-01 | 1.00e+00 | 1.261 | 1 | 5 | 301 |
GO:0035556 | intracellular signal transduction | 3.46e-01 | 1.00e+00 | 1.251 | 1 | 9 | 303 |
GO:0019901 | protein kinase binding | 3.59e-01 | 1.00e+00 | 1.186 | 1 | 18 | 317 |
GO:0007411 | axon guidance | 3.61e-01 | 1.00e+00 | 1.177 | 1 | 5 | 319 |
GO:0008283 | cell proliferation | 3.69e-01 | 1.00e+00 | 1.137 | 1 | 14 | 328 |
GO:0030054 | cell junction | 3.76e-01 | 1.00e+00 | 1.102 | 1 | 5 | 336 |
GO:0015031 | protein transport | 3.81e-01 | 1.00e+00 | 1.081 | 1 | 11 | 341 |
GO:0003723 | RNA binding | 3.81e-01 | 1.00e+00 | 1.076 | 1 | 18 | 342 |
GO:0005730 | nucleolus | 4.02e-01 | 1.00e+00 | 0.399 | 3 | 66 | 1641 |
GO:0046982 | protein heterodimerization activity | 4.14e-01 | 1.00e+00 | 0.924 | 1 | 8 | 380 |
GO:0009986 | cell surface | 4.32e-01 | 1.00e+00 | 0.843 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 4.41e-01 | 1.00e+00 | 0.804 | 1 | 24 | 413 |
GO:0055085 | transmembrane transport | 4.58e-01 | 1.00e+00 | 0.729 | 1 | 8 | 435 |
GO:0007596 | blood coagulation | 4.74e-01 | 1.00e+00 | 0.664 | 1 | 11 | 455 |
GO:0044267 | cellular protein metabolic process | 4.88e-01 | 1.00e+00 | 0.605 | 1 | 20 | 474 |
GO:0048471 | perinuclear region of cytoplasm | 5.08e-01 | 1.00e+00 | 0.523 | 1 | 8 | 502 |
GO:0044281 | small molecule metabolic process | 5.10e-01 | 1.00e+00 | 0.252 | 2 | 20 | 1211 |
GO:0005509 | calcium ion binding | 5.28e-01 | 1.00e+00 | 0.442 | 1 | 11 | 531 |
GO:0045087 | innate immune response | 5.70e-01 | 1.00e+00 | 0.275 | 1 | 15 | 596 |
GO:0005794 | Golgi apparatus | 5.79e-01 | 1.00e+00 | 0.241 | 1 | 9 | 610 |
GO:0006351 | transcription, DNA-templated | 6.10e-01 | 1.00e+00 | -0.004 | 2 | 57 | 1446 |
GO:0007165 | signal transduction | 7.27e-01 | 1.00e+00 | -0.331 | 1 | 13 | 907 |
GO:0008270 | zinc ion binding | 7.62e-01 | 1.00e+00 | -0.467 | 1 | 27 | 997 |
GO:0005739 | mitochondrion | 7.62e-01 | 1.00e+00 | -0.469 | 1 | 23 | 998 |
GO:0005524 | ATP binding | 8.49e-01 | 1.00e+00 | -0.848 | 1 | 31 | 1298 |
GO:0046872 | metal ion binding | 8.51e-01 | 1.00e+00 | -0.858 | 1 | 29 | 1307 |
GO:0016021 | integral component of membrane | 9.48e-01 | 1.00e+00 | -1.459 | 1 | 17 | 1982 |